{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:54:07Z","timestamp":1793987647060,"version":"4.8.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T00:00:00Z","timestamp":1752451200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Perivascular epithelioid cell tumors (PEComa) are a rare family of mesenchymal tumors that include several subtypes. There are very limited data describing the natural history of patients with extra-visceral retroperitoneal PEComas of the retroperitoneum. The aim of this study is to describe the clinical features, treatment patterns, outcomes, and diagnostic challenges of primary extra-visceral retroperitoneal or abdominopelvic PEComa over the past decade.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patients and Methods<\/jats:title>\n            <jats:p>This is a retrospective analysis of all extra-visceral, non-renal, retroperitoneal, or abdominopelvic PEComas treated at participating centers over the past 10\u00a0years.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 77 patients from 13 centers were included. The median age at diagnosis was 56\u00a0years (range 18\u201381\u00a0years); 73% were female. The median size was 9\u00a0cm. The tumor was classified as a PEComa not otherwise specified (NOS) in 55 (71%), sclerosing PEComa in 11 (15%), and angiomyolipoma (AML) in 11 (15%). Treatment intent was curative in 59 (77%) patients. Adjuvant radiation was given in five (8%) patients, and (neo)adjuvant systemic therapy was given to six (10%). Of those who did not undergo curative intent treatment, four (22%) patients had metastatic disease and three (17%) had primary unresectable disease. With a median follow-up of 26\u00a0months (2.3\u2013147\u00a0months), 24 (40%) of the 59 patients having curative treatment had recurred. Recurrence rates differed by subtype, with 20 (37%) of the PEComa NOS group, 3 (27%) of the sclerosing PEComa group, and 1 (9%) of the AML group developing recurrence. The estimated 5-year OS of the whole cohort was 63% and 75% for the curative intent group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Retroperitoneal and abdominopelvic PEComas show distinct behaviors by subtype. PEComa NOS had the highest recurrence and mortality, sclerosing PEComa showed intermediate risk, and AML was indolent. Histological classification is essential for prognosis and management.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1245\/s10434-025-17787-8","type":"journal-article","created":{"date-parts":[[2025,7,14]],"date-time":"2025-07-14T21:01:45Z","timestamp":1752526905000},"page":"7817-7828","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Natural History of Primary Retroperitoneal Extra-Visceral Perivascular Epithelioid Cell Tumors (PEC): A Study from Transatlantic and Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)"],"prefix":"10.1245","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3235-2946","authenticated-orcid":false,"given":"Eyal","family":"Mor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameer","family":"Apte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Nessim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Almond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Vincenzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Antonio Gonzalez","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Cranmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aviram","family":"Nissan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Henriques","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Albertsmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilda","family":"Knoblauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Barlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Z.","family":"Keung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Grignani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Gyorki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,14]]},"reference":[{"issue":"3","key":"17787_CR1","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1097\/00000478-199203000-00013","volume":"16","author":"F Bonetti","year":"1992","unstructured":"Bonetti F, Pea M, Martignoni G, et al. PEC and sugar. Am J Surg Pathol. 1992;16(3):307\u20138. https:\/\/doi.org\/10.1097\/00000478-199203000-00013.","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"17787_CR2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/0046-8177(91)90298-4","volume":"22","author":"F Bonetti","year":"1991","unstructured":"Bonetti F, Pea M, Martignoni G, Zamboni G, Iuzzolino P. Cellular heterogeneity in lymphangiomyomatosis of the lung. Hum Pathol. 1991;22(7):727\u20138. https:\/\/doi.org\/10.1016\/0046-8177(91)90298-4.","journal-title":"Hum Pathol"},{"issue":"1","key":"17787_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1111\/J.1365-2559.2005.02316.X","volume":"48","author":"JL Hornick","year":"2006","unstructured":"Hornick JL, Fletcher CDM. PEComa: what do we know so far? Histopathology. 2006;48(1):75\u201382. https:\/\/doi.org\/10.1111\/J.1365-2559.2005.02316.X.","journal-title":"Histopathology"},{"issue":"2","key":"17787_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.32074\/1591-951X-213","volume":"113","author":"M Sbaraglia","year":"2021","unstructured":"Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO classification of soft tissue tumours: news and perspectives. Pathologica. 2021;113(2):70. https:\/\/doi.org\/10.32074\/1591-951X-213.","journal-title":"Pathologica"},{"issue":"1","key":"17787_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/JSO.24893","volume":"117","author":"PL Rutkowski","year":"2018","unstructured":"Rutkowski PL, Mullen JT. Management of the \u201cother\u201d retroperitoneal sarcomas. J Surg Oncol. 2018;117(1):79\u201386. https:\/\/doi.org\/10.1002\/JSO.24893.","journal-title":"J Surg Oncol"},{"issue":"16","key":"17787_CR6","doi-asserted-by":"publisher","first-page":"2934","DOI":"10.1002\/cncr.33618","volume":"127","author":"S Stacchiotti","year":"2021","unstructured":"Stacchiotti S, Frezza AM, Blay J, et al. Ultra-rare sarcomas: a consensus paper from the connective tissue oncology society community of experts on the incidence threshold and the list of entities. Cancer. 2021;127(16):2934\u201342. https:\/\/doi.org\/10.1002\/cncr.33618.","journal-title":"Cancer"},{"issue":"12","key":"17787_CR7","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1097\/01.PAS.0000173232.22117.37","volume":"29","author":"AL Folpe","year":"2005","unstructured":"Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29(12):1558\u201375. https:\/\/doi.org\/10.1097\/01.PAS.0000173232.22117.37.","journal-title":"Am J Surg Pathol"},{"key":"17787_CR8","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.EUCR.2018.03.012","volume":"19","author":"E Singer","year":"2018","unstructured":"Singer E, Yau S, Johnson M. Retroperitoneal PEComa: case report and review of literature. Urol Case Rep. 2018;19:9. https:\/\/doi.org\/10.1016\/J.EUCR.2018.03.012.","journal-title":"Urol Case Rep"},{"issue":"17","key":"17787_CR9","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1158\/1078-0432.CCR-19-0288","volume":"25","author":"R Sanfilippo","year":"2019","unstructured":"Sanfilippo R, Jones RL, Blay JY, et al. Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas). Clin Cancer Res. 2019;25(17):5295\u2013300. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0288.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"17787_CR10","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","volume":"250","author":"PA Clavien","year":"2009","unstructured":"Clavien PA, Barkun J, de Oliveira ML, et al. The Clavien-Dindo classification of surgical complications. Ann Surg. 2009;250(2):187\u201396. https:\/\/doi.org\/10.1097\/SLA.0b013e3181b13ca2.","journal-title":"Ann Surg"},{"issue":"7","key":"17787_CR11","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/0046-8177(91)90298-4","volume":"22","author":"F Bonetti","year":"1991","unstructured":"Bonetti F, Pea M, Martignoni G, Zamboni G, Iuzzolino P. Cellular heterogeneity in lymphangiomyomatosis of the lung. Hum Pathol. 1991;22(7):727\u20138. https:\/\/doi.org\/10.1016\/0046-8177(91)90298-4.","journal-title":"Hum Pathol"},{"issue":"3","key":"17787_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.3109\/00313029109063563","volume":"23","author":"M Pea","year":"1991","unstructured":"Pea M, Bonetti F, Zamboni G, et al. Melanocyte-marker-HMB-45 is regularly expressed in angiomyolipoma of the kidney. Pathology. 1991;23(3):185\u20138. https:\/\/doi.org\/10.3109\/00313029109063563.","journal-title":"Pathology"},{"issue":"3","key":"17787_CR13","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.radcr.2022.11.042","volume":"18","author":"K Dhaliwal","year":"2023","unstructured":"Dhaliwal K, Marslender S. Malignant retroperitoneal PEComa: a case report with emphasis on radiological findings. Radiol Case Rep. 2023;18(3):1358\u201363. https:\/\/doi.org\/10.1016\/j.radcr.2022.11.042.","journal-title":"Radiol Case Rep"},{"key":"17787_CR14","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/541626","author":"JS Bleeker","year":"2012","unstructured":"Bleeker JS, Quevedo JF, Folpe AL. Malignant perivascular epithelioid cell neoplasm: risk stratification and treatment strategies. Sarcoma. 2012. https:\/\/doi.org\/10.1155\/2012\/541626.","journal-title":"Sarcoma"},{"issue":"12","key":"17787_CR15","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1097\/01.PAS.0000173232.22117.37","volume":"29","author":"AL Folpe","year":"2005","unstructured":"Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin: a clinicopathologic study of 26 cases and review of the literature. Am J Surg Pathol. 2005;29(12):1558\u201375. https:\/\/doi.org\/10.1097\/01.PAS.0000173232.22117.37.","journal-title":"Am J Surg Pathol"},{"key":"17787_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-3-62","author":"AM Koenig","year":"2009","unstructured":"Koenig AM, Quaas A, Ries T, et al. Perivascular epitheloid cell tumour (PEComa) of the retroperitoneum - A rare tumor with uncertain malignant behaviour: a case report. J Med Case Rep. 2009. https:\/\/doi.org\/10.1186\/1752-1947-3-62.","journal-title":"J Med Case Rep"},{"key":"17787_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.eucr.2016.02.004","volume":"6","author":"D D\u2019Andrea","year":"2016","unstructured":"D\u2019Andrea D, Hanspeter E, D\u2019Elia C, Martini T, Pycha A. Malignant perivascular epithelioid cell neoplasm (PEComa) of the pelvis: a case report. Urol Case Rep. 2016;6:36\u20138. https:\/\/doi.org\/10.1016\/j.eucr.2016.02.004.","journal-title":"Urol Case Rep."},{"key":"17787_CR18","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1097\/PAS.0b013e318161dc34","volume":"32","author":"JL Hornick","year":"2008","unstructured":"Hornick JL, Fletcher CD. Sclerosing PEComa: clinicopathologic analysis of a distinctive variant with a predilection for the retroperitoneum. Am J Surg Pathol. 2008;32:493.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"17787_CR19","doi-asserted-by":"publisher","first-page":"41","DOI":"10.5334\/jbsr.1536","volume":"102","author":"N Vos","year":"2018","unstructured":"Vos N, Oyen R. Renal angiomyolipoma: the good, the bad, and the ugly. J Belg Soc Radiol. 2018;102(1):41. https:\/\/doi.org\/10.5334\/jbsr.1536.","journal-title":"J Belg Soc Radiol"},{"key":"17787_CR20","unstructured":"Rout P, Leslie SW. Renal angiomyolipoma; 2025."},{"issue":"1","key":"17787_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.eururo.2016.01.048","volume":"70","author":"JR Bhatt","year":"2016","unstructured":"Bhatt JR, Richard PO, Kim NS, et al. Natural history of renal angiomyolipoma (AML): most patients with large AMLs >4cm can be offered active surveillance as an initial management strategy. Eur Urol. 2016;70(1):85\u201390. https:\/\/doi.org\/10.1016\/j.eururo.2016.01.048.","journal-title":"Eur Urol"},{"issue":"4 Pt 1","key":"17787_CR22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.juro.2015.07.126","volume":"195","author":"AS Flum","year":"2016","unstructured":"Flum AS, Hamoui N, Said MA, et al. Update on the diagnosis and management of renal angiomyolipoma. J Urol. 2016;195(4 Pt 1):834\u201346. https:\/\/doi.org\/10.1016\/j.juro.2015.07.126.","journal-title":"J Urol"},{"key":"17787_CR23","unstructured":"Folpe AL, Mentzel T, Lehr HA, Fisher C, Balzer BL, Weiss SW. Perivascular epithelioid cell neoplasms of soft tissue and gynecologic origin a clinicopathologic study of 26 cases and review of the literature. http:\/\/journals.lww.com\/ajsp"},{"issue":"33","key":"17787_CR24","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.21.01728","volume":"39","author":"AJ Wagner","year":"2021","unstructured":"Wagner AJ, Ravi V, Riedel RF, et al. nab-Sirolimus for patients with malignant perivascular epithelioid cell tumors. J Clin Oncol. 2021;39(33):3660\u201370. https:\/\/doi.org\/10.1200\/JCO.21.01728.","journal-title":"J Clin Oncol"},{"issue":"21","key":"17787_CR25","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.12998\/wjcc.v7.i21.3524","volume":"7","author":"Z Touloumis","year":"2019","unstructured":"Touloumis Z, Giannakou N, Sioros C, et al. Retroperitoneal perivascular epithelioid cell tumours: a case report and review of literature. World J Clin Cases. 2019;7(21):3524\u201334. https:\/\/doi.org\/10.12998\/wjcc.v7.i21.3524.","journal-title":"World J Clin Cases"},{"key":"17787_CR26","doi-asserted-by":"crossref","unstructured":"Retroperitoneal perivascular epithelioid cell tumours: a case report and review of literature. Accessed 11 July 2024. https:\/\/www.wjgnet.com\/2307-8960\/full\/v7\/i21\/3524.htm","DOI":"10.12998\/wjcc.v7.i21.3524"},{"key":"17787_CR27","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-12-3","author":"M Wildgruber","year":"2014","unstructured":"Wildgruber M, Becker K, Feith M, Gaa J. Perivascular epitheloid cell tumor (PEComa) mimicking retroperitoneal liposarcoma. World J Surg Oncol. 2014. https:\/\/doi.org\/10.1186\/1477-7819-12-3.","journal-title":"World J Surg Oncol"},{"issue":"1","key":"17787_CR28","doi-asserted-by":"publisher","first-page":"51","DOI":"10.12809\/HKJR1414242","volume":"18","author":"VYK To","year":"2015","unstructured":"To VYK, Tsang JPK, Yeung TW, Yuen MK. Retroperitoneal sclerosing perivascular epithelioid cell tumour. Hong Kong J Radiol. 2015;18(1):51\u20136. https:\/\/doi.org\/10.12809\/HKJR1414242.","journal-title":"Hong Kong J Radiol"},{"issue":"1","key":"17787_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.3892\/OL.2015.3210","volume":"10","author":"W Liang","year":"2015","unstructured":"Liang W, Xu C, Chen F. Primary retroperitoneal perivascular epithelioid cell neoplasm: a case report. Oncol Lett. 2015;10(1):469\u201372. https:\/\/doi.org\/10.3892\/OL.2015.3210.","journal-title":"Oncol Lett"},{"issue":"1","key":"17787_CR30","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5114\/PJP.2017.67623","volume":"68","author":"M Danilewicz","year":"2017","unstructured":"Danilewicz M, Strzelczyk JM, Wagrowska-Danilewicz M. Perirenal perivascular epithelioid cell tumor (PEC oma) coexisting with other malignancies: a case report. Pol J Pathol. 2017;68(1):92\u20135. https:\/\/doi.org\/10.5114\/PJP.2017.67623.","journal-title":"Pol J Pathol"},{"issue":"2","key":"17787_CR31","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1590\/1516-3180.2017.0120050717","volume":"137","author":"YB Cihan","year":"2019","unstructured":"Cihan YB, Kut E, Ko\u00e7 A. Recurrence of retroperitoneal localized perivascular epithelioid cell tumor two years after initial diagnosis: case report. Sao Paulo Med J. 2019;137(2):206\u20138. https:\/\/doi.org\/10.1590\/1516-3180.2017.0120050717.","journal-title":"Sao Paulo Med J"},{"issue":"3","key":"17787_CR32","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1007\/S00595-013-0541-5","volume":"44","author":"G Pata","year":"2014","unstructured":"Pata G, Tironi A, Solaini L, Tiziano T, Ragni F. Perivascular epithelioid cell tumor located retroperitoneally with pulmonary lymphangioleiomyomatosis: report of a case. Surg Today. 2014;44(3):572\u20136. https:\/\/doi.org\/10.1007\/S00595-013-0541-5.","journal-title":"Surg Today"},{"key":"17787_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/J.EUCR.2018.03.012","volume":"19","author":"E Singer","year":"2018","unstructured":"Singer E, Yau S, Johnson M. Retroperitoneal PEComa: case report and review of literature. Urol Case Rep. 2018;19:9\u201310. https:\/\/doi.org\/10.1016\/J.EUCR.2018.03.012.","journal-title":"Urol Case Rep"},{"issue":"21","key":"17787_CR34","doi-asserted-by":"publisher","first-page":"3524","DOI":"10.12998\/wjcc.v7.i21.3524","volume":"7","author":"Z Touloumis","year":"2019","unstructured":"Touloumis Z, Giannakou N, Sioros C, et al. Retroperitoneal perivascular epithelioid cell tumours: a case report and review of literature. World J Clin Cases. 2019;7(21):3524\u201334. https:\/\/doi.org\/10.12998\/wjcc.v7.i21.3524.","journal-title":"World J Clin Cases"},{"key":"17787_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-3-62","author":"AM Koenig","year":"2009","unstructured":"Koenig AM, Quaas A, Ries T, et al. Perivascular epitheloid cell tumour (PEComa) of the retroperitoneum - A rare tumor with uncertain malignant behaviour: a case report. J Med Case Rep. 2009. https:\/\/doi.org\/10.1186\/1752-1947-3-62.","journal-title":"J Med Case Rep"},{"issue":"3","key":"17787_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/S12301-011-0018-Y","volume":"17","author":"M Valiathan","year":"2011","unstructured":"Valiathan M, Sunil BP, Rao L, Geetha V, Hedge P. Sclerosing PEComa: a histologic surprise. Afr J Urol. 2011;17(3):97\u2013100. https:\/\/doi.org\/10.1007\/S12301-011-0018-Y.","journal-title":"Afr J Urol"},{"key":"17787_CR37","doi-asserted-by":"publisher","DOI":"10.5489\/CUAJ.413","author":"G Guglielmetti","year":"2013","unstructured":"Guglielmetti G, De Angelis P, Mondino P, Terrone C, Volpe A. PEComa of soft tissues can mimic lymph node relapse in patients with history of testicular seminoma. J Can Urol Assoc. 2013. https:\/\/doi.org\/10.5489\/CUAJ.413.","journal-title":"J Can Urol Assoc"},{"issue":"2","key":"17787_CR38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/S11605-007-0462-Y","volume":"13","author":"TE Lans","year":"2009","unstructured":"Lans TE, Van Ramshorst GH, Hermans JJ, Den Bakker MA, Tran TCK, Kazemier G. Perivascular epithelioid cell tumor of the retroperitoneum in a young woman resulting in an abdominal chyloma. J Gastrointest Surg. 2009;13(2):389\u201392. https:\/\/doi.org\/10.1007\/S11605-007-0462-Y.","journal-title":"J Gastrointest Surg"},{"issue":"8","key":"17787_CR39","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44325","volume":"15","author":"D Usuga","year":"2023","unstructured":"Usuga D, Atri E, Alloush F, Poppiti R, Bhandari A. A large retroperitoneal liposarcoma mimicking an angiomyolipoma on pre-operative imaging: a case report. Cureus. 2023;15(8):e44325. https:\/\/doi.org\/10.7759\/cureus.44325.","journal-title":"Cureus"},{"key":"17787_CR40","doi-asserted-by":"publisher","DOI":"10.11604\/pamj.2020.37.210.26269","author":"ML Anthony","year":"2020","unstructured":"Anthony ML, Durgapal P, Joshi P, et al. Diagnostic pitfall of a rare variant of angiomyolipoma, epithelioid angiomyolipoma - A case report. Pan Afr Med J. 2020. https:\/\/doi.org\/10.11604\/pamj.2020.37.210.26269.","journal-title":"Pan Afr Med J"},{"issue":"13","key":"17787_CR41","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.3748\/wjg.v30.i13.1926","volume":"30","author":"S Yan","year":"2024","unstructured":"Yan S, Lu JJ, Chen L, Cai WH, Wu JZ. Hepatic perivascular epithelioid cell tumors: the importance of preoperative diagnosis. World J Gastroenterol. 2024;30(13):1926\u201333. https:\/\/doi.org\/10.3748\/wjg.v30.i13.1926.","journal-title":"World J Gastroenterol"},{"key":"17787_CR42","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.8020","author":"R Marcu","year":"2019","unstructured":"Marcu R, Diaconu C, Constantin T, et al. Minimally invasive biopsy in retroperitoneal tumors (Review). Exp Ther Med. 2019. https:\/\/doi.org\/10.3892\/etm.2019.8020.","journal-title":"Exp Ther Med"},{"issue":"1","key":"17787_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2023.107298","volume":"50","author":"W Nardi","year":"2024","unstructured":"Nardi W, Nicolas N, El Zein S, et al. Diagnostic accuracy and safety of percutaneous core needle biopsy of retroperitoneal tumours. Eur J Surg Oncol. 2024;50(1):107298. https:\/\/doi.org\/10.1016\/j.ejso.2023.107298.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"17787_CR44","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1111\/ans.15723","volume":"90","author":"R Young","year":"2020","unstructured":"Young R, Snow H, Hendry S, et al. Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single-centre study. ANZ J Surg. 2020;90(4):497\u2013502. https:\/\/doi.org\/10.1111\/ans.15723.","journal-title":"ANZ J Surg"},{"issue":"33","key":"17787_CR45","doi-asserted-by":"publisher","first-page":"3660","DOI":"10.1200\/JCO.21.01728","volume":"39","author":"AJ Wagner","year":"2021","unstructured":"Wagner AJ, Ravi V, Riedel RF, et al. nab-Sirolimus for patients with malignant perivascular epithelioid cell tumors. J Clin Oncol. 2021;39(33):3660\u201370. https:\/\/doi.org\/10.1200\/JCO.21.01728.","journal-title":"J Clin Oncol"},{"issue":"3","key":"17787_CR46","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1097\/CAD.0000000000000324","volume":"27","author":"C Batereau","year":"2016","unstructured":"Batereau C, Kn\u00f6sel T, Angele M, et al. Neoadjuvant or adjuvant sirolimus for malignant metastatic or locally advanced perivascular epithelioid cell tumors. Anticancer Drugs. 2016;27(3):254\u20138. https:\/\/doi.org\/10.1097\/CAD.0000000000000324.","journal-title":"Anticancer Drugs"},{"key":"17787_CR47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/1477-7819-12-46","volume":"12","author":"F Bergamo","year":"2014","unstructured":"Bergamo F, Maruzzo M, Basso U, et al. Neoadjuvant sirolimus for a large hepatic perivascular epithelioid cell tumor (PEComa). World J Surg Oncol. 2014;12:46. https:\/\/doi.org\/10.1186\/1477-7819-12-46.","journal-title":"World J Surg Oncol"},{"issue":"17","key":"17787_CR48","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.1158\/1078-0432.CCR-19-0288","volume":"25","author":"R Sanfilippo","year":"2019","unstructured":"Sanfilippo R, Jones RL, Blay JY, et al. Role of chemotherapy, VEGFR inhibitors, and mTOR inhibitors in advanced perivascular epithelioid cell tumors (PEComas). Clin Cancer Res. 2019;25(17):5295\u2013300. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-0288.","journal-title":"Clin Cancer Res"}],"updated-by":[{"DOI":"10.1245\/s10434-025-18021-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000}}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17787-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-17787-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-17787-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T14:04:36Z","timestamp":1758549876000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-17787-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,14]]},"references-count":48,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["17787"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-17787-8","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,14]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1245\/s10434-025-18021-1","URL":"https:\/\/doi.org\/10.1245\/s10434-025-18021-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Michael J Wagner reports consulting\/advisory board fees from Adaptimmune, Deciphera, Aadi, Epizyme, PharmaEssentia, Springworks and research support from Edgewood Oncology. Giovanni Grignani reports honoraria from Bayer, Eisai, Eli Lilly and Company, Merck, Novartis, Pfizer, PharmaMar; Incyte, Decyphera, and Boehringer Ingelheim; consulting or advisory role for Bayer, Eisai, Eli Lilly & Company, Novartis, Pfizer, and PharmaMar; and research funding from Bayer, Novartis, and PharmaMar. Jason L. Hornick reports being a consultant for Aadi Bioscience, TRACON Pharmaceuticals, and Adaptimmune.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}